ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,042Medicare Part D Prescriptions Filled, Including Refills

Rank: 73 out of 1844

$767K Total Retail Price of All Prescriptions

Rank: 115 out of 1844

491 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
22% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 491 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

16% of this provider’s 491 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

1% of this provider’s 13,622 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
SIMVASTATIN 742 676 1 3
LISINOPRIL 682 637 2 4
OMEPRAZOLE 511 455 3 5
LEVOTHYROXINE SODIUM 503 439 4 1
AMLODIPINE BESYLATE 484 457 5 6
FUROSEMIDE 407 388 6 7
HYDROCHLOROTHIAZIDE 395 377 7 9
HYDROCODONE-ACETAMINOPHEN 373 315 S3 8 2
CARVEDILOL 370 349 9 22
POTASSIUM CHLORIDE 333 301 10 16
PRAVASTATIN SODIUM 326 308 11 10
METOPROLOL SUCCINATE 287 277 12 14
ATENOLOL 270 244 13 17
WARFARIN SODIUM 265 214 14 13
METOPROLOL TARTRATE 213 194 15 11
LOSARTAN POTASSIUM 212 203 16 24
METFORMIN HCL 198 179 17 8
ATORVASTATIN CALCIUM 193 180 18 12
FENTANYL 192 161 S2 19 66
GLIMEPIRIDE 177 164 20 35
ALLOPURINOL 164 164 21 29
ZOLPIDEM TARTRATE 151 147 22 23
SPIRONOLACTONE 151 127 22 60
CLOPIDOGREL 138 129 24 34
CITALOPRAM HBR 138 129 24 19
ALENDRONATE SODIUM 134 120 26 25
LISINOPRIL-HYDROCHLOROTHIAZIDE 134 123 26 20
DIOVAN 130 123 28 58
FLUOXETINE HCL 130 103 28 41
LOSARTAN-HYDROCHLOROTHIAZIDE 128 125 30 47
GABAPENTIN 121 70 31 15
MELOXICAM 114 92 32 28
TRIAMTERENE-HCTZ 114 105 32 48
DONEPEZIL HCL 113 113 34 26
ZETIA 105 93 35 81
LANTUS 104 99 36 42
VERAPAMIL ER 103 102 37 98
ENALAPRIL MALEATE 99 98 38 69
CLONIDINE HCL 98 90 39 64
PANTOPRAZOLE SODIUM 94 91 40 32
ADVAIR DISKUS 88 86 41 51
PLAVIX 84 79 42 61
FLUTICASONE PROPIONATE 83 76 43 50
CRESTOR 80 75 44 30
PREDNISONE 80 75 44 40
POLYETHYLENE GLYCOL 3350 78 77 46 39
TAMSULOSIN HCL 77 74 47 27
SERTRALINE HCL 76 71 48 21
NEXIUM 73 60 49 31
ESCITALOPRAM OXALATE 69 69 50 52
ETODOLAC 62 62 51 178
RANITIDINE HCL 62 46 51 38
SINGULAIR 61 51 53 102
FINASTERIDE 55 52 54 137
CEPHALEXIN 54 53 55 56
TORSEMIDE 54 51 55 118
NIFEDIPINE ER 54 51 55 154
FLOVENT HFA 53 44 58 328
DIOVAN HCT 50 50 59 96
KLOR-CON M20 50 47 59 54
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 1, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.